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demonstrate that volume reduction and shape changes are valuable
components in the treatment of congestive heart failure following
infarction. Ejection fraction improved, volume was reduced, and
clinical status improved by New York Heart Association (NYHA)
functional classification status. Moreover, five-year survival was
very gratifying, especially when compared to conventional therapy.
The effects of ventricular restoration have been studied and
referenced in our report (1). These include improvement of systolic
and diastolic function, confirmed by the centerline method and
pressure-volume loop studies. The operation’s primary physiolog-
ical impact is on the remote noninfarcted myocardium and has
been well described.
Our study did not report hemodynamics because we believe that
little can be extrapolated from such data. It is well known that
heart failure progresses independently of hemodynamic status and
is directly related to ventricular size and shape changes (2,3).
Indeed, patients with markedly dilated hearts and advanced heart
failure often have normal cardiac output and pulmonary pressures
at rest. Our reporting is, therefore, consistent with the majority of
clinical trials of heart failure, few of which assert that acute resting
hemodynamic changes are of functional or prognostic significance.
Hemodynamics, however, may be of value during exercise.
Consequently, conversion of 67% in NYHA functional class III/IV
category to 85% in class I/II seems an effective functional coun-
terpart. In the meanwhile, the recently documented neuro-
hormonal consequences of ventricular restoration are very perti-
nent to the reviewer’s comments regarding “cause and effect” (4).
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Cardiac Magnetic
Resonance-Directed Intervention
in Non–ST-Segment Elevation
Acute Coronary Syndrome
I read with great interest the study by Plein et al. (1) on the use of
cardiac magnetic resonance (CMR) imaging to determine the
presence of significant coronary stenosis in patients with non–ST-
segment elevation acute coronary syndromes (NSTE-ACS). The
investigators showed an impressive sensitivity (96%) and specificity
(83%) to predict significant coronary stenosis using combined
myocardial function, perfusion, viability (employing late enhance-
ment), and coronary anatomy. They also pointed out that the
diagnostic yield of combining only perfusion, wall motion, and late
enhancement was similar without the addition of CMR angiog-
raphy, representing a significant reduction in scanning time.
The advent of evidence-based international guidelines that all
patients with NSTE-ACS should undergo early (72 h) revascu-
larization (2,3) has created both an enormous burden on world-
wide health care systems and long inpatient waiting times for
intervention (4). A more precise risk-stratification of those patients
with a diagnosis of NSTE-myocardial infarction, such as that
advocated by the Plein et al. (1) study, would prevent exposing
patients to unnecessary risk and markedly alleviate the extra burden
on health care systems. This is particularly relevant to this study as
only 53% of subjects had a positive troponin level and thereby
fulfilled the definition of NSTE-ACS and evidence-based criteria
for early intervention.
The difficulty of accurate risk-stratification highlights the im-
portance of the study by Plein et al. (1), but the real strength of
CMR lies in not only detecting coronary artery stenoses, but in
directing interventional therapy. Although 56 of the 68 patients
studied were found to have coronary artery disease, a more
profound question is whether the stenotic vessel supplied a
territory that was viable or ischemic, as these are the stenoses that,
when treated, result in beneficial ventricular remodeling, progno-
sis, or reduction in symptoms (5). This information is inherent in
the CMR technique and therefore readily already available to the
investigators. Further analysis of the data would determine how
appropriate the intervention was, and allow the potential cost
benefit of a single CMR scan to be calculated.
*Nick G. Bellenger, MD
*Wessex Cardiothoracic Centre
E Level, East Wing
Tremona Road
Southampton
Hants
SO16 6YD
United Kingdom
E-mail: nickbellenger@doctors.org.uk
doi:10.1016/j.jacc.2005.05.016
REFERENCES
1. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan
MU. Assessment of non–ST-segment elevation acute coronary syn-
dromes with cardiac magnetic resonance imaging. J Am Coll Cardiol
2004;44:2173–81.
2. Cannon CP, WeintraubWS, Demopoulos LA, et al. TACTICS (Treat
Angina with Aggrastat and determine Cost of Therapy with an Invasive
or Conservative strategy)—Thrombolysis In Myocardial Infarction-18
Investigators. Comparison of early invasive and conservative strategies
in patients with unstable coronary syndromes treated with glycoprotein
IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879–87.
3. Invasive compared to non-invasive treatment in unstable coronary-
artery disease: FRISC II prospective randomised multi-center study.
Fragmin and fast revascularization during inStability in Coronary artery
disease Investigators. Lancet 1999;354:708–15.
563JACC Vol. 46, No. 3, 2005 Correspondence
August 2, 2005:560–4
4. Bellenger NG, Eichhofer J, Crone D, Curzen N. Hospital stay in
patients with non–ST-elevation acute coronary syndromes. Lancet
2004;363:1399–400.
5. Bellenger NG, Yousef ZR, Rajappan K, Marber M, Pennell DJ. Infarct
zone viability influences ventricular remodeling of an occluded infarct-
related artery. Heart 2005;91:478–83.
REPLY
We are grateful to Dr. Bellenger for his interesting comments. We
share his enthusiasm regarding the potential of cardiac magnetic
resonance (CMR) to provide a guide to revascularization in patients
presenting with acute coronary syndromes and also in other clinical
scenarios.
Some of the information Dr. Bellenger requests is indeed
inherent in our data (1). Of the 56 patients with significant
coronary artery disease (CAD) in our study, 49 had perfusion
defects (the sensitivity of perfusion analysis to detect the presence
of CAD on X-ray angiography was therefore 87.5%, as reported in
our study). Seven patients thus had no perfusion defects on CMR
despite the presence of significant CAD on X-ray angiography.
Only three patients in our population showed transmural scar on
late contrast-enhanced CMR imaging. Two of these patients
underwent percutaneous intervention to vessels supplying myocar-
dium that appeared on CMR to be predominantly nonviable (one
of these is shown in Figure 4C of our study [1]).
However, other than reporting these results, our study design
does not permit us to draw conclusions regarding the appropriate-
ness of revascularization decisions in these patients. In the absence
of a true standard for the detection of “significant” CAD, we used
X-ray angiography as the reference test to determine the need for
coronary revascularization therapy. We cannot therefore conclude
that in patients with discrepant results between CMR and X-ray
angiography, coronary revascularization was inappropriate or un-
necessary.
Our study (1) is the first report of using CMR in patients with
acute coronary syndromes. In this work it was our aim to establish
whether CMR can be applied safely to this group of patients and
whether it can accurately detect CAD. We fully agree with Dr.
Bellenger that the potential future role of CMR, as we have
discussed in our report, could exceed this relatively narrow appli-
cation we have studied, and could include guiding revascularization
decisions by providing comprehensive data on myocardial func-
tion, perfusion, and viability. This potential role should be ex-
plored in future work with an appropriately designed study.
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